EM2503D "What Drives the Survival Gap? Cardiometabolic Risk of People with HIV on Antiretroviral Therapy" (IM GR - 030725)

Overview

Purpose and Overview

This presentation explores the evolving landscape of cardiovascular and metabolic complications in people living with HIV (PWH) in the modern antiretroviral therapy (ART) era. It examines trends in survival and causes of mortality, emphasizing the role of chronic inflammation, immune activation, and ART-related metabolic effects in increasing the risk of cardiovascular disease (CVD), bone mineral loss, and non-AIDS cancers. The talk also highlights the limitations of conventional CVD risk calculators in PWH and discusses evidence-based strategies for risk assessment, prevention, and management. By integrating findings from epidemiologic studies and clinical trials, this presentation aims to provide a comprehensive understanding of cardiometabolic health in HIV care and inform future mitigation strategies.

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Analyze the Trends in Survival and Causes of Mortality in People with HIV in Modern ART Era
  • Examine the Rates and Determinants of Cardiometabolic Complications on HIV:Cardiovascular Disease, Bone Mineral Loss and Non-AIDS Cancers
  • Assess the Roles of Background Risk, HIV Parameters and Antiretroviral Exposure on Risk of Chronic Complications.
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
03/11/2025
Course expires: 
04/11/2025
Cost:
$0.00
Rating: 
0

Faculty

Photo: First Last, M.D.
Roger Bedimo M.D.
Professor of Internal Medicine
Division of Infectious Diseases and Geographic Medicine

Accreditation

Available Credit

  • 1.00 AMA

Register/Take course

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome